Haesook Teresa Kim

Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.

Wobma H, Kapadia M, Kim HT, Alvarez-Calderon F, Baumeister SHC, Duncan C, Forrest S, Gorfinkel L, Huang J, Lehmann LE, Li H, Schwartz M, Koreth J, Ritz J, Kean LS, Whangbo JS.

Blood Adv. 2023 08 22. 7(16):4647-4657. PMID: 37603347

Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD.

Maurer K, Ho VT, Inyang E, Cutler C, Koreth J, Shapiro RM, Gooptu M, Romee R, Nikiforow S, Antin JH, Wu CJ, Ritz J, Soiffer RJ, Kim HT.

Blood Adv. 2023 08 08. 7(15):3903-3915. PMID: 37156098

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy.

Bachireddy P, Azizi E, Burdziak C, Nguyen VN, Ennis CS, Maurer K, Park CY, Choo ZN, Li S, Gohil SH, Ruthen NG, Ge Z, Keskin DB, Cieri N, Livak KJ, Kim HT, Neuberg DS, Soiffer RJ, Ritz J, Alyea EP, Pe'er D, Wu CJ.

Cell Rep. 2023 Aug 29. 42(8):113011. PMID: 37556329

Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.

Shapiro RM, Kim HT, Ansuinelli M, Guleria I, Cutler CS, Koreth J, Gooptu M, Antin JH, Kelkar A, Ritz J, Wu CJ, Soiffer RJ, Ho VT, Nikiforow S, Romee R.

Blood Adv. 2023 08 08. 7(15):4080-4088. PMID: 37216223

Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

Koshy AG, Kim HT, Liegel J, Arnason J, Ho VT, Antin JH, Joyce R, Cutler C, Gooptu M, Nikiforow S, Logan EK, Elavalakanar P, Narcis M, Stroopinsky D, Avigan ZM, Boussi L, Stephenson S, El Banna H, Bindal P, Cheloni G, Avigan DE, Soiffer RJ, Rosenblatt J.

Blood. 2023 Jun 15. 141(24):2932-2943. PMID: 36862975

Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells.

Maurer K, Kim HT, Garrity HM, Liney D, Cutler C, Antin JH, Koreth J, Ritz J, Shapiro RM, Romee R, Ho VT, Gooptu M, Soiffer RJ, Wu CJ, Nikiforow S.

Blood Adv. 2023 06 13. 7(11):2431-2435. PMID: 36595453

Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis.

Gooptu M, Kim HT, Jacobsen E, Fisher DC, LaCasce A, Ho VT, Cutler CS, Koreth J, Soiffer RJ, Antin JH, Berliner N, Nikiforow S.

Blood Adv. 2023 06 13. 7(11):2309-2316. PMID: 35439287

Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.

Fathi AT, Kim HT, Soiffer RJ, Levis MJ, Li S, Kim AS, DeFilipp Z, El-Jawahri A, McAfee SL, Brunner AM, Amrein PC, Mims AS, Knight LW, Kelley D, Bottoms AS, Perry LH, Wahl JL, Brock J, Breton E, Marchione DM, Ho VT, Chen YB.

Clin Cancer Res. 2023 06 01. 29(11):2034-2042. PMID: 37014667

Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.

Wobma HM, Kapadia M, Kim HT, Alvarez-Calderon F, Baumeister S, Duncan C, Forrest S, Gorfinkel L, Huang J, Lehmann LE, Li H, Schwartz MA, Koreth J, Ritz J, Kean LS, Whangbo JS.

Blood Adv. 2023 May 24. PMID: 37224510

Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.

Vergara-Cadavid J, Johnson PC, Kim HT, Yi A, Sise ME, Leaf DE, Hanna PE, Ho VT, Cutler CS, Antin JH, Gooptu M, Kelkar AH, Wells SL, Nikiforow S, Koreth J, Romee R, Soiffer RJ, Shapiro RM, Gupta S.

Transplant Cell Ther. 2023 07. 29(7):455.e1-455.e9. PMID: 37015320